New pill aims to stop stomach bug in its tracks
Disease control
Recruiting now
This study tests an experimental drug called CDI-988 in 40 healthy adults aged 18 to 49. Participants receive either the drug or a placebo before being exposed to the norovirus stomach bug. The goal is to see if CDI-988 can reduce symptoms like diarrhea and vomiting and lower the…
Phase: PHASE1, PHASE2 • Sponsor: Cocrystal Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 15:12 UTC